PulseAugur
EN
LIVE 12:10:38
中文(ZH) 港交所刘颖:2018年推出18A章以来,已有90家生物科技公司在港上市

HKEX sees 90 biotech listings; tech chapter attracts AI firms

The Hong Kong Stock Exchange has seen significant activity under its Chapter 18A listing rules, with 90 biotech companies listing and raising HK$142.9 billion since 2018. Additionally, the Chapter 18C mechanism for special technology companies has facilitated listings for AI, robotics, and autonomous driving firms. In contrast, the A-share market experienced a broad decline, with over 4000 stocks falling, despite some gains in industrial gases and semiconductors. AI

IMPACT Facilitates capital for AI and tech companies, potentially accelerating innovation and market growth.

RANK_REASON The article reports on significant fundraising and listing activity on the Hong Kong Stock Exchange under specific regulatory chapters, impacting biotech and technology sectors. [lever_c_demoted from significant: ic=1 ai=0.4]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Hong Kong Stock Exchange's Liu Ying: Since the launch of Chapter 18A in 2018, 90 biotech companies have listed in Hong Kong

    6月11日,港交所董事总经理、首次公开招股审查联席主管刘颖透露,自2018年推出18A章以来,已有90家生物科技公司成功在港上市,累计募资达1429亿港元。其中,2025年有17家18A公司上市,2026年前五个月再添6家。与此同时,在为特专科技公司设立的18C章上市机制方面,2024年及2025年分别有3家和5家企业通过该机制上市,2026年前五个月已有10家公司通过18C机制实现上市。目前,以18C章上市的行业主要包括AI、机器人,以及自动驾驶公司等。(界面)